Dorenbaum Alejandro 4
4 · Reneo Pharmaceuticals, Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Dorenbaum Alejandro
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2022-12-09+125,000→ 125,000 totalExercise: $1.80Exp: 2032-12-08→ Common Stock (125,000 underlying) - Gift
Common Stock
2022-08-12−22,348→ 30,000 total
Footnotes (1)
- [F1]The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.